Oncotarget
The cover for issue 35 of Oncotarget features Figure 4, "The in vivo pre- or post- topical application of BAY 11-7082 prevents the acidic bile-induced deregulation of cancer-related miRNA markers in 10-day exposed murine HM," by Vageli, et al.
Delivering a RAS protease halts tumor growth |
https://doi.org/10.18632/oncotarget.27714 Vania Vidimar, Roman A. Melnyk, and Karla J.F. Satchell |
3265-3266 |
PDF | How to cite | Order a Reprint |
Targeting 14-3-3ε-CDC25A interactions to trigger apoptotic cell death in skin cancer |
https://doi.org/10.18632/oncotarget.27700 Thomas R. Holmes, Jenan Al-Matouq, Matti Holmes, Lauren Nicola, Justin C. Rudd, Sándor Lovas, and Laura A. Hansen |
3267-3278 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release | Order a Reprint |
Sequencing for an interdisciplinary molecular tumor board in patients with advanced breast cancer: experiences from a case series |
https://doi.org/10.18632/oncotarget.27704 Christina Walter, Andreas Hartkopf, Andre Koch, Marion Klaumünzer, Martin Schulze, Eva-Maria Grischke, Florin-Andrei Taran, Sara Brucker, Florian Battke, and Saskia Biskup |
3279-3285 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release | Order a Reprint |
Ghrelin ameliorates tumor-induced adipose tissue atrophy and inflammation via Ghrelin receptor-dependent and -independent pathways |
https://doi.org/10.18632/oncotarget.27705 Haiming Liu, Jiaohua Luo, Bobby Guillory, Ji-an Chen, Pu Zang, Jordan K. Yoeli, Yamileth Hernandez, Ian (In-gi) Lee, Barbara Anderson, Mackenzie Storie, Alison Tewnion, and Jose M. Garcia |
3286-3302 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release | Order a Reprint |
The temporal effects of topical NF-κB inhibition, in the in vivo prevention of bile-related oncogenic mRNA and miRNA phenotypes in murine hypopharyngeal mucosa: a preclinical model |
https://doi.org/10.18632/oncotarget.27706 Dimitra P. Vageli, David Kasle, Sotirios G. Doukas, Panagiotis G. Doukas, and Clarence T. Sasaki |
3303-3314 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release | Order a Reprint |
Therapeutic applications of the selective high affinity ligand drug SH7139 extend beyond non-Hodgkin’s lymphoma to many other types of solid cancers |
https://doi.org/10.18632/oncotarget.27709 Rod Balhorn, and Monique Cosman Balhorn |
3315-3349 |
Abstract | PDF | Full Text | How to cite | Press Release | Order a Reprint |
Correction: Non-toxic dose of liposomal honokiol suppresses metastasis of hepatocellular carcinoma through destabilizing EGFR and inhibiting the downstream pathways |
https://doi.org/10.18632/oncotarget.27369 Jianhong Yang, Heying Pei, Hong Luo, Afu Fu, Hansuo Yang, Jia Hu, Chengjian Zhao, LuLu Chai, Xiang Chen, Ximing Shao, Chunyu Wang, Wenshuang Wu, Li Wan, Haoyu Ye, Qiang Qiu, Aihua Peng, Yuquan Wei, Li Yang, and Lijuan Chen |
3350-3351 |
Correction | PDF | How to cite |
Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC